Actively Recruiting
Evaluation of HEArt invoLvement in Patients With FABRY Disease
Led by Wuerzburg University Hospital · Updated on 2022-07-07
650
Participants Needed
1
Research Sites
1626 weeks
Total Duration
On this page
Sponsors
W
Wuerzburg University Hospital
Lead Sponsor
C
Competence Network Heart Failure
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.
CONDITIONS
Official Title
Evaluation of HEArt invoLvement in Patients With FABRY Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Genetically confirmed Fabry disease
- Signed informed consent
- Age 18 years or older
You will not qualify if you...
- No informed consent given
- Withdrawal of informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Wuerzburg University Hospital
Würzburg, Bavaria, Germany, 97080
Actively Recruiting
Research Team
P
Peter Nordbeck, MD, PhD
CONTACT
J
Jonas Muentze, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here